News

  1. Australia Delivers Certainty For US Biotechs In 2025: Avance Clinical Offers Fast Start-Up, Regulatory Predictability, And R&D Rebates 5/28/2025

    As regulatory uncertainty grows in the United States, US biotechs are increasingly looking to Australia as a stable and predictable launchpad for early-phase clinical trials. With its globally accepted regulatory framework, accelerated timelines, and 43.5% R&D rebate, Australia offers a compelling advantage — and Avance Clinical, Australia’s leading early-phase specialist CRO, is delivering the GlobalReady solution to help biotechs de-risk, conserve capital and accelerate their programs.

  2. Reduce Complexity For Oncology Sites, Sponsors, Patients, And Caregivers 5/27/2025

    Medable Inc. announced its next-generation digital oncology trial offering specifically designed to reduce operational complexity for sites and sponsors.

  3. Meet With Avance Clinical At ASCO 2025 In Chicago 5/20/2025

    Avance Clinical will attend and host a booth at the upcoming American Society of Clinical Oncology (ASCO) Annual Meeting, scheduled from May 30 to June 3, 2025, at McCormick Place in Chicago, Illinois. This premier event brings together oncology professionals from around the world to connect, collaborate, and inspire advancements in cancer care.

  4. Avance Clinical Honored With Frost & Sullivan's 2025 Global Customer Value Leadership Award 5/20/2025

    Frost & Sullivan has named Avance Clinical the recipient of its 2025 Global Customer Value Leadership Award in the biotech contract research organization (CRO) sector, highlighting the company’s outstanding performance in delivering exceptional client value through innovation, service excellence, and technology-enabled trial optimization.

  5. Novotech Welcomes New Investment From GIC, Temasek, And Existing Investor TPG To Accelerate Global Growth 5/14/2025

    Novotech, a globally recognized full-service biotech specialist clinical research organization (CRO), announced today that affiliates of GIC and Temasek have signed binding agreements to acquire a significant stake in the company, with the additional capital earmarked to accelerate its global growth. Existing investor TPG will also reinvest through its TPG Asia fund.

  6. Novotech Report Reveals Global Surge In Infectious Disease Trials As Industry Nears 2,000 Studies Since 2020 5/14/2025

    Novotech a globally recognized full-service clinical research organization (CRO) and scientific advisory partner for biotech and small- to mid-sized pharmaceutical companies seeking to advance drug development, has released a new report analyzing the evolving infectious disease clinical trial landscape. This report provides critical strategic insights for pharmaceutical and biotech companies navigating the complexities of global infectious disease research and development in 2025. 

  7. Novotech Identifies Strategic Opportunities In Idiopathic Pulmonary Fibrosis Trials With Release Of Global Market Insights 5/14/2025

    Sydney, April 2025 – Novotech, a globally recognized full-service clinical research organization (CRO) and scientific advisory partner for biotech and small- to mid-sized pharmaceutical companies seeking to advance drug development, has released an in-depth report on the global clinical trial landscape for Idiopathic Pulmonary Fibrosis (IPF). The report offers strategic insights and comprehensive analysis critical for biotech and pharmaceutical companies navigating the complexities of IPF clinical research and drug development. 

  8. Crucial Data Solutions Sets Another Industry Benchmark: TrialKit Now Available As A Native macOS App 4/29/2025

    Crucial Data Solutions, Inc. (CDS), the pioneer behind the all-inclusive eClinical platform TrialKit, today announced the launch of TrialKit as a native macOS app—an industry-first for clinical trial software. This milestone makes TrialKit the only platform across all key interfaces: web, mobile (iOS and Android), and now Mac. With this latest expansion, CDS reinforces its leadership in modernizing clinical research technology and delivering unmatched flexibility for sponsors and CROs worldwide.

  9. Avance Clinical To Showcase Asia-Pacific Clinical Trial Expertise At BIO Korea 2025 4/15/2025

    Avance Clinical, a leading full-service global Contract Research Organization (CRO) specializing in high-quality, agile clinical biotech research services, will attend BIO Korea 2025 to meet with biotechs and share clinical trial capabilities across the region including Australia, New Zealand, South Korea, Taiwan, North America and beyond.

  10. Novotech Expands South Korean Presence With New Hospital Trial Site Deal 4/4/2025

    Australian CRO Novotech has signed a memorandum of understanding with the Kyungpook National University Hospital (KNUH), furthering its partnership strategy in South Korea.